p21 promotes oncolytic adenoviral activity in ovarian cancer and is a potential biomarker
<p>Abstract</p> <p>The oncolytic adenovirus <it>dl</it>922-947 replicates selectively within and lyses cells with a dysregulated Rb pathway, a finding seen in > 90% human cancers. <it>dl</it>922-947 is more potent than wild type adenovirus and the E1B-del...
Main Authors: | Lockley Michelle, Pirlo Katrina J, Salako Michael A, Archibald Kyra, Chelala Claude, Connell Claire M, Flak Magdalena B, Wheatley Sally P, Balkwill Frances R, McNeish Iain A |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-07-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/9/1/175 |
Similar Items
-
Strategies to Optimise Oncolytic Viral Therapies: The Role of Natural Killer Cells
by: Elaine Y. L. Leung, et al.
Published: (2021-07-01) -
Activity of Adenoviral E1A CR2 Deletion Mutants in Ovarian Cancer
by: Lockley, Michelle
Published: (2008) -
Impact of Autophagy in Oncolytic Adenoviral Therapy for Cancer
by: Hiroshi Tazawa, et al.
Published: (2017-07-01) -
The role of the innate immune system in oncolytic adenoviral therapy
by: Spurrell, Emma Louise
Published: (2009) -
NK Cells Augment Oncolytic Adenovirus Cytotoxicity in Ovarian Cancer
by: Elaine Y.L. Leung, et al.
Published: (2020-03-01)